 |
|
|
|
Drugs in Development
People of OyaGen
Science of Editing Enzymes
News
Investors
Links
Contact Us
Home
|
 |
|
OyaGen in the News
Publications from OyaGen
Miller JH, Presnyak V, Smith HC (2007) The dimerization domain of HIV-1 viral infectivity factor Vif is required to block APOBEC3G incorporation with virions. Retrovirology 2007, 4:81News Features
Will health reform be shot in arm for biotech firms?
Rochester, NY - Democrat & Chronicle, April 2, 2010OyaGen's founder and CSO receives a Bill and Melinda Gates Foundation Award for his academic research.
Gates Foundation Invests in 106 Novel Ideas for Global Health, October 2008
University of Rochester Medical Center Receives $100,000 Grand
Challenges Explorations Grant for Innovative Global Health, October, 2008UR to Receive Millions for Ongoing AIDS Research
Rochester, NY - Rochester Business Journal, March 12, 2007Rochester, NY Named One of the Top 20 Tech Cities in the Country
Rochester, NY - Greater Rochester Enterprise advertisment, 2005OyaGen blazing path toward anti-AIDS drug
Rochester, NY - Democrat & Chronicle, September 1, 2005Study Holds Promise For New Way To Fight HIV
University of Rochester Press Release - September 1, 2005OyaGen Scientific Advisor Board Meeting - photo
New York, NY - April, 2005Television interview with Dr. Smith
Rochester, NY - R News, Cable Channel 9, January, 2004
Windows Media Player -
QuickTime Player -
Television interview with Dr. Smith
Rochester, NY - WOKR13.TV - News Source 13, January, 2004
Rochester Start-Up Offers Groundbreaking Discovery in HIV Research
Company Press ReleaseUR Invests in Anti-HIV Startup
Rochester, NY - Democrat & Chronicle, January 12, 2004If you need to download a free QuickTime Player go to http://www.apple.com/quicktime/download/
